Growth Metrics

Alnylam Pharmaceuticals (ALNY) Share-based Compensation Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -34.72%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.80%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 10.78%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.65%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.65%
Dec 31, 2025 18.76%
Sep 30, 2025 -5.47%
Jun 30, 2025 54.18%
Mar 31, 2025 24.63%
Dec 31, 2024 27.15%
Sep 30, 2024 11.14%
Jun 30, 2024 40.67%
Mar 31, 2024 -6.62%
Dec 31, 2023 7.00%
Sep 30, 2023 19.72%
Jun 30, 2023 30.95%
Mar 31, 2023 4.93%
Dec 31, 2022 -13.55%
Sep 30, 2022 40.69%
Jun 30, 2022 -0.14%
Mar 31, 2022 -2.94%
Dec 31, 2021 16.81%
Sep 30, 2021 -10.01%
Jun 30, 2021 12.98%
Mar 31, 2021 41.67%
Sep 30, 2020 50.81%
Jun 30, 2020 36.56%
Mar 31, 2020 30.06%
Dec 31, 2019 47.45%
Sep 30, 2019 70.14%
Jun 30, 2019 48.86%
Mar 31, 2019 10.91%
Dec 31, 2018 21.70%
Sep 30, 2018 102.50%
Jun 30, 2018 76.72%
Mar 31, 2018 33.47%
Sep 30, 2017 61.67%
Jun 30, 2017 73.06%
Mar 31, 2017 41.13%
Dec 31, 2016 56.32%
Sep 30, 2016 11.14%
Jun 30, 2016 61.56%
Mar 31, 2016 96.92%
Dec 31, 2015 78.65%
Sep 30, 2015 17.65%
Jun 30, 2015 9.19%
Mar 31, 2015 37.68%
Dec 31, 2014 48.76%
Sep 30, 2014 -15.48%
Jun 30, 2014 -15.34%
Mar 31, 2014 10.69%
Dec 31, 2013 6.35%
Sep 30, 2013 14.69%
Jun 30, 2013 -24.28%
Mar 31, 2013 -16.74%
Dec 31, 2012 -11.60%
Sep 30, 2012 -15.61%